| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V4962 | CAY10595 | 916047-16-0 | CAY10595 is a novel, selective, potentand orally bioavailable CRTH2/DP2 receptor antagonist with the potential for the treatment of allergic inflammatory diseases. |
|
V4960 | CCG 203769 | 410074-60-1 | CCG 203769 is a novel, potent and selective G protein signaling (RGS4) inhibitor with an IC50of 17 nM for blocking the RGS4-Gαoprotein-protein interaction in vitro. |
|
V4774 | CG-806 | 1370466-81-1 | CG-806 (also known as CG-026806) is a novel, highly potent, non-covalent/reversible small molecule, panFLT3/BTKMulti-Kinase inhibitor. |
|
V4773 | CHMFL-BTK-01 | 2095280-64-9 | CHMFL-BTK-01 (compound 9) is a novel, potent, highly selective and irreversible/covalentBTK (Bruton's tyrosine kinase)inhibitor with anIC50of 7 nM. |
|
V4834 | CHMFL-PI3KD-317 | 2244992-76-3 | CHMFL-PI3KD-317 is a novel, highly potent, selective and orally bioavailablePI3Kδinhibitor, with anIC50of 6 nM, it exhibits over 10-1500 fold selectivity over other class I, II and III PIKK family isoforms, such as PI3Kα (IC50, 62.6 nM), PI3Kβ (IC50, 284 nM), PI3Kγ (IC50, 202.7 nM), PIK3C2A (IC50, >10000 nM), PIK3C2B (IC50, 882.3 nM), VPS34 (IC50, 1801.7 nM), PI4KIIIA (IC50, 574.1 nM) and PI4KIIIB (IC50, 300.2 nM). |
|
V4821 | CI-1044 | 197894-84-1 | CI-1044 is a novel, potent and orally bioavailablePDE4(phosphodiesterase 4) inhibitor withIC50s of 0.29, 0.08, 0.56, 0.09 μM forPDE4A5,PDE4B2,PDE4C2andPDE4D3, respectively. |
|
V5000 | Clovoxamine fumarate | 54739-21-8 | Clovoxamine fumarate (formerly also known as DU 23811) is a potent non-TCA (tricyclic antidepressant) with a dual action in blocking the reuptake of both noradrenaline and serotonin. |
|
V4876 | CM-037 | 896795-60-1 | CM037 is a novel, potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitor which acts by binding within the aldehyde binding pocket of ALDH1A1 in a competitive mode of inhibition. |
|
V5048 | CMPD 7 (AZ1992) | 2220184-50-7 | CMPD 7 (also known as AZ1992) is a novel, highly potent and selective CDK12 inhibitor with an IC50of 491 nM in an enzymatic assay. |
|
V4525 | Cobimetinib R-enantiomer | 934660-94-3 | Cobimetinib R-enantiomer is the less active R-enantiomer of Cobimetinib (formerly GDC-0973, RG7420 or XL-518;Cotellic) which is a small-molecule MEK1 inhibitor approved for cancer treatment. |
|
V5061 | CPFX4158 | 1804962-84-2 | CPFX4158 is a novel mannose analog that can be potentially used in transgenic humanized-CEACAM6 mouse as antibacterial agent. |
|
V5130 | CS-476 (NSC302998) | 41177-35-9 | CS 476 (NSC-302998), an orally bioavailable sulphonylurea analog, has been shown to be a potent hypoglycaemic agent. |
|
V5147 | Cyclopiazonic acid (CPA) | 18172-33-3 | Cyclopiazonic acid (also known as CPA), a neurotoxic secondary metabolite (SM) produced byA. |
|
V4924 | CYM5520 | 1449747-00-5 | CYM5520 (CYM-5520), a pyrrolyl ketone analog, is a novel, a potent, selective, and allosteric agonist of sphingosine-1-phosphate receptor 2 with anti-osteoporosis activity. |
|
V4646 | Cytochalasin E | 36011-19-5 | Cytochalasin E, an epoxide-containing analog of cytochalasin B, is a natural product acting as an autophagy inhibitor which enhances chemotherapy-induced cell death andpotently and selectively inhibits the growth of endothelial cells (IC50< 1 nM), impairing angiogenesis and tumor growth. |
|
V4631 | Daphnoretin | 2034-69-7 | Daphnoretin (formerly also know as NSC291852) is a novel and potent coumarin derivative with anti-cancer activity. |
|
V4829 | DDD85646 | 1215010-55-1 | DDD85646 (DDD-85646) is a novel and potent inhibitor of T. |
|
V4798 | Diazepinomicin | 733035-26-2 | Diazepinomicin (formerly known as TLN-4601; ECO-4601; TLN 4601; BU 4664L), a secondary metabolite produced byMicromonospora sp,is a novel and potent small-molecule inhibitor of the RAS-ERK/RAF/MAPK signaling pathway with potential antineoplastic activity. |
|
V4634 | Diflapolin | 724453-98-9 | Diflapolin is reported to be the first potent dual soluble epoxide hydrolase (sEH)/5-lipoxygenase-activating protein (FLAP) inhibitor. |
|
V5175 | Dolastatin 10 | 110417-88-4 | Dolastatin 10 (also known as DLS 10), a peptide-based natural product isolated from the marine molluskDolabela auricularia, is a highly potent antimitotic peptide that inhibits tubulin polymerization with an IC50 value of 1.2μM. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
